Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT03074318 · TERMINATED
Trial details
- NCT number
- NCT03074318
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2020-11-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.